Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays

International Journal of Antimicrobial Agents

Volumn 43, Issue 1, 2014, Pages 32-39

  Abbanat, Darren ^a   Shang, Wenchi ^a   Amsler, Karen ^a   Santoro, Colleen ^a   Baum, Ellen ^a   Crespo Carbone, Steven ^a   Lynch, A Simon ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Antibiotic resistance; Biofilm; Ceftobiprole; Staphylococcus

Indexed keywords

CEFTOBIPROLE; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM COLONY; BACTERIUM ISOLATE; BIOASSAY; BIOFILM; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DILUTION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EXPOSURE; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

ANTIBIOTIC RESISTANCE; BIOFILM; CEFTOBIPROLE; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; BIOFILMS; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TIME FACTORS;

EID: 84890788524     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.09.013     Document Type: Conference Paper

References (31)

1. N. Høiby, T. Bjarnsholt, M. Givskov, S. Molin, and O. Ciofu Antibiotic resistance of bacterial biofilms Int J Antimicrob Agents 35 2010 322 332
2. K. Lewis Riddle of biofilm resistance Antimicrob Agents Chemother 45 2001 999 1007
3. A.S. Lynch, and D. Abbanat New antibiotic agents and approaches to treat biofilm-associated infections Expert Opin Ther Pat 20 2010 1373 1387
4. P.D. Fey Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr Opin Microbiol 13 2010 610 615
5. P.I. Hair, and S.J. Keam Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia Drugs 67 2007 1483 1512
6. E. Walencka, B. Sadowska, S. Rozalska, W. Hryniewicz, and B. Rozalska Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin Folia Microbiol (Praha) 51 2006 381 386
7. Innovotech The MBEC™ Physiology & Genetics (P&G) assay. Instruction manual 2011 Innovotech Inc. Edmonton, Canada
8. J.N. Anderl, M.J. Franklin, and P.S. Stewart Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin Antimicrob Agents Chemother 44 2000 1818 1824
9. Z. Zheng, and P.S. Stewart Penetration of rifampin through Staphylococcus epidermidis biofilms Antimicrob Agents Chemother 46 2002 900 903
10. D. Vázquez-Sánchez, O. Habimana, and A. Holck Impact of food-related environmental factors on the adherence and biofilm formation of natural Staphylococcus aureus isolates Curr Microbiol 66 2013 110 121
11. E. Mataraci, and S. Dosler In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms Antimicrob Agents Chemother 56 2012 6366 6371
12. K.R. Peck, S.W. Kim, S-I. Jung, Y-S. Kim, W.S. Oh, and J.Y. Lee Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis Chemotherapy 49 2003 189 193
13. C.R. Arciola, S. Gamberini, D. Campoccia, L. Visai, P. Speziale, and L. Baldassarri A multiplex PCR method for the detection of all five individual genes of ICA locus in Staphylococcus epidermidis. A survey on 400 clinical isolates from prosthesis-associated infections J Biomed Mater Res A 75 2005 408 413
14. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Document M100-S19 2009 CLSI Wayne, PA
15. B. Cunha, Castanheira D., Rex J.H., and Kaplan M.H. Antimicrobial drug summaries B Cunha, Antibiotic essentials 2005 Physicians Press Royal Oak, MI 365 483
16. D.P. Healy, R.E. Polk, M.L. Garson, D.T. Rock, and T.J. Comstock Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers Antimicrob Agents Chemother 31 1987 393 397
17. M.A. Kielhofner Trimethoprim-sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions Tex Heart Inst J 17 1990 86 93
18. B. Murthy, and A. Schmitt-Hoffmann Pharmacokinetics and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity Clin Pharmacokinet 47 2008 21 33
19. ® package insert 2006 Pfizer
20. P.T. Mannisto, R. Mantyla, J. Mattila, S. Nykanen, and U. Lamminsivu Comparison of pharmacokinetics of sulfadiazine and sulfamethoxazole after intravenous infusion J Antimicrob Chemother 9 1982 461 470
21. M. Rybak, B. Lomaestro, J.C. Rotschafer, R. Moellering Jr., W. Craig, and M. Billeter Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Am J Health Syst Pharm 66 2009 82 98
22. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Document M07-A7 7th ed. 2009 CLSI Wayne, PA
23. H. Anwar, J.L. Strap, and J.W. Costerton Susceptibility of biofilm cells of Pseudomonas aeruginosa to bactericidal actions of whole blood and serum FEMS Microbiol Lett 71 1992 235 241
24. M. Monzon, C. Oteiza, J. Leiva, M. Lamata, and B. Amorena Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics Diagn Microbiol Infect Dis 44 2002 319 324
25. S. Roveta, A. Marchese, and G.C. Schito Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. Int J Antimicrob Agents 31 2008 321 328
26. M.E. Stryjewski, and G.R. Corey Treatment protocols for bacterial endocarditis and infection of electrophysiologic cardiac devices J.L. Pace, M.E. Rupp, R.G. Finch, Biofilms, infection, and antimicrobial therapy 2006 CRC Press Boca Raton, FL 427 448
27. K.L. LaPlante, and S. Woodmansee Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis Antimicrob Agents Chemother 53 2009 3880 3886
28. K. Smith, A. Perez, G. Ramage, C.G. Gemmell, and S. Lang Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin Int J Antimicrob Agents 33 2009 374 378
29. H.F. Chambers Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus Antimicrob Agents Chemother 49 2005 884 888
30. J. Fernandez, D. Abbanat, W. Shang, W. He, K. Amsler, and J. Hastings Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus Antimicrob Agents Chemother 56 2012 1476 1484
31. P. Tattevin, L. Basuino, D. Bauer, B.A. Diep, and H.F. Chambers Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 54 2010 610 613